Heatstroke 4
Heatstroke 4
Heatstroke 4
Heatstroke
Abhijit Goyal‑Honavar, Annsmol P. Markose, Kundavaram Paul Prabhakar Abhilash
Department of Emergency Medicine, Christian Medical College, Vellore, Tamil Nadu, India
Downloaded from http://journals.lww.com/cmii by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW
Abstract
nYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8KKGKV0Ymy+78= on 03/27/2024
Heat‑related illnesses are a common cause of morbidity and mortality in tropical climates; they range from innocuous heat cramps to life‑threatening
heat strokes, and yet, the data regarding their evaluation and management are far from definitive. It is a condition with an evolving definition,
the most recent by the Japanese Association for Acute Medicine eschewing the use of specific temperature cutoffs. Cooling measures such as
evaporative cooling are of utmost importance in bringing about a rapid decrease in core body temperature, with evidence showing the effectiveness
of invasive measures and other techniques to reduce organ dysfunction unsatisfactory. High‑quality prospective studies comparing various
modalities of treatment is the need of the hour, and the implementation of preventive measures must be more widely undertaken.
Key words: Definition, evaluation prognosis, heat stroke, heat‑related illness, management
Address for correspondence: Dr. Abhijit Goyal‑Honavar, Department of Emergency Medicine, Christian Medical College, Vellore, Tamil Nadu, India.
E‑Mail: abhijitgoyalhonavar@gmail.com
Introduction
Heat‑related illnesses: A spectrum of severity
Heat‑related illnesses are a collection of disorders resulting from a mismatch between the metabolic production of heat and
physiological measures to ensure heat loss.[1] They present with a constellation of symptoms and signs consequent to failure of
thermoregulation and are characterized by hyperthermia, defined as the elevation of core body temperature above the normal
range of 36°C–37.5°C. It is important to differentiate this elevation of core body temperature from fever, which is induced by
cytokine activation during inflammation and is regulated at the level of the hypothalamus. They have a spectrum of severity,
ranging from heat cramps to heatstroke (HS).
Heat cramps are the most innocuous of the heat‑related illnesses, manifesting as brief cramps following periods of exertion. Despite
core body temperatures between 37°C and 39°C, mental function is unaltered in such patients. The painful, involuntary muscle
spasms that characterize heat cramps are caused by fluid and electrolyte loss following excessive exertion in hot environments.
Further along the spectrum of heat‑related illnesses lies heat exhaustion, wherein generalized weakness, fatigue, nausea, headache,
vertigo, and syncope predominate. Much like heat cramps, mental status is not disturbed despite a core body temperature of 37°C–40°C.
Heat cramps and heat exhaustion respond well to conservative measures, such as rest in a cool area and replenishing fluids and
nutritional needs of the body.
Heatstroke: A paradigm shift
Farthest along the spectrum of severity lies HS, which is characterized by much higher morbidity and mortality than the other
heat‑related illnesses, with some estimates of mortality ranging from 10% to 50%.[2] Despite its well‑recognized severity, even at
Access this article online This is an open access journal, and articles are distributed under the terms of the Creative
Quick Response Code: Commons Attribution‑NonCommercial‑ShareAlike 4.0 License, which allows others to
Website: remix, tweak, and build upon the work non‑commercially, as long as appropriate credit
www.cmijournal.org is given and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com
DOI:
10.4103/cmi.cmi_4_20 How to cite this article: Goyal-Honavar A, Markose AP, Abhilash KP.
Heatstroke. Curr Med Issues 2020;18:87-93.
Renal renal impairments requiring inpatient hospital care levels ≥1.2 mg/dL
Cardiovascular ‑ ‑
Respiratory ‑ ‑
JCS: Jouvet Coma Scale, DIC: Deviance information criterion, JAAM: Japanese Association for Acute Medicine, GCS: Glasgow Coma Scale,
JAAM‑HS‑WG: JAAM‑Heat Stroke‑Working Group, HS: Heat stroke
despite their core differences in the initiation, the propagation The presence of comorbid conditions adds to the temperature
of the HS response and sepsis bear certain similarities. dysregulation that causes HS. For example, diabetes mellitus
causes decreased sweat gland innervation and cutaneous Other differentials to consider are listed in Table 2.
vasodilatation via its effect on the autonomic nervous system.
Some therapeutic measures may negatively impact the Prognostic Factors
temperature balance, such as the advent of SGLT2 inhibitors,
A study performed in the medical intensive care unit (ICU) of
which may themselves predispose to HS.
our center[17] reports that more than three‑quarter of patients
Another example of a drug that increases susceptibility to HS admitted with HS developed multi‑organ dysfunction. They
Downloaded from http://journals.lww.com/cmii by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW
is topiramate, which finds utility in the treatment of migraine noted respiratory failure to be the most common form of organ
and epilepsy. Up to 10% of pediatric patients may develop dysfunction.
oligohydrosis, and in combination with environmental factors
Predictors of multi‑organ dysfunction were recognized
or other medication it precipitates HS.
to be creatinine phosphokinase level >1000 U/L,
nYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8KKGKV0Ymy+78= on 03/27/2024
Heat shock response; the role of heat shock proteins metabolic acidosis, elevated liver enzymes, aspartate
Heat shock proteins (HSPs) are a group of molecules that aminotransferase/alanine aminotransferase more than twice
play a critical role in achieving thermotolerance and protect normal, lactate dehydrogenase >500 U/L, and leukocytosis
from stress‑induced cellular damage induced by heat, cold, defined as white blood cell count >11,000/cu mm.
and ultraviolet radiation. [3,8] Advanced age, preexisting
A study from France by Argaud et al. among non‑exertional
illnesses, dehydration, insomnia, and poor physical fitness
HSs during the 2003 Paris heat wave considered all patients
are associated with low levels of expression of HSPs such
with core body temperature >40°C found much higher
as HSP70, and these factors thus predispose to developing
mortality among elderly patients with classical HS than
classical HSs.
younger patients with exertional HS (63% vs. 15%). They
Genetic factors in heatstroke noted that the risk of mortality rose substantially in patients
Recent evidence points to the role of genetic factors in the presenting with anuria, coma, or cardiovascular failure, as well
predisposition to HS, such as the calsequestrin 1 gene on as those who developed DIC during the course of treatment.[18]
chromosome 1.[16] This gene is known to modulate skeletal Another study during the same period in France used a different
muscle contraction by regulating the release of calcium cutoff for core body temperature (38.5°C) and identified
stored in the sarcoplasmic reticulum. Differential capacities of previous treatment with diuretics, living in an institution,
muscles among individuals to modulate and release heat may age >80 years, the presence of cardiac disease or cancer, core
play a part in causing thermal dysregulation. temperature >40°C, systolic arterial pressure <100 mmHg,
GSC scale <12, and transportation to hospital in ambulance as
Differential Diagnosis prognostic factors associated with death in nonexertional HS.
The most important differentials considered in a patient with A third French multicenter study examining patients affected
severe hyperthermia include neuroleptic malignant syndrome by the same heat wave using Bouchama’s original definition
and malignant hyperthermia. found high Simplified Acute Physiology Score II score, initial
As previously mentioned, HS is characterized by the high body temperature, prolonged prothrombin time, and the
preceding history of exercise and/or exposure to high ambient use of vasoactive drugs in the 1st day of ICU admission to be
temperature. This typical history can help differentiate it from predictors of hospital death.
other causes of hyperthermia. Interestingly, Misset et al. also found that the risk of hospital
Neuroleptic malignant syndrome death was almost twice as high among ICUs without
Neuroleptic malignant syndrome is an idiosyncratic reaction air conditioning as compared to those equipped with air
associated with the consumption of first‑generation, and less conditioning. There was no significant difference among ICUs
commonly, second‑generation antipsychotics. It is recognized with and without air conditioning in terms of beds, senior
by the presence of “lead pipe” muscle rigidity, altered mental physicians, or the number of heatstroke patients admitted per
status, choreoathetosis, tremors, and evidence of autonomic ICU.[19] Hence, it is our unbridled recommendation that all
dysfunction such as dysrhythmias, diaphoresis, and labile critical care units anticipating management of cases of HS
blood pressures. should be equipped with air‑conditioning facilities, as a simple
but effective means of lowering its mortality.
Malignant hyperthermia
Hifumi et al.[20] from Japan, using the JAAM‑HS criteria,
Malignant hyperthermia is an autosomal dominant disorder,
noted that patients who developed DIC were more than twice
caused by mutations in the Ryanodine calcium channel
as likely to suffer hospital mortality, with worsening mortality
receptor. It manifests following treatment with anesthetic
as the DIC score increased.
agents, most commonly succinylcholine and halothane.
Clinical findings include muscle rigidity, especially masseter These factors are summarised in Table 3. Thus, it appears that
stiffness, sinus tachycardia, hypercarbia, and skin cyanosis the development of coagulopathy significantly worsens the
with mottling. outcome of HS. In our center, we recommend the use of DIC,
core body temperature >40°C, and significant renal or hepatic have been performed confirming the superiority of any initial
dysfunction in determining the prognosis of HS patients. cooling method and conclusive data on the comparative
efficacy of these are needed.
Treatment Also lacking is evidence to support a specific temperature
Patients with HS often present after a significant delay and with end‑point, though various studies have shown endpoints
compromised airway, breathing, circulation, or a combination between 38°C and 39.6°C to be safe.[28] The largest of these
Downloaded from http://journals.lww.com/cmii by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW
of these. Immediate recognition of this clinical syndrome will case series concluded that a rectal temperature of 39.4°C is a
enable concurrent initiation of urgent stabilizing measures as safe and achievable endpoint.[3]
well as definitive cooling methods. Since both the degree and the duration of hyperthermia
Following this, the management of a case of HS involves contribute to the damage inflicted by exertional HS, many
nYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8KKGKV0Ymy+78= on 03/27/2024
preventing organ dysfunction and supporting organ systems authors conclude that lowering the core body temperature
[Figure 1]. within the “golden hour,” or the 1st h following HS is critical in
mitigating the mortality and sequelae caused by the episode.[29-31]
Cooling the patient: How, how much, and how fast?
The former, i.e., cooling the victim, is the cornerstone of In the experience of the authors of this review, evaporative
therapy and requires the creation of a gradient for heat loss and convectional cooling via application of sprayed water and
between the skin and environment. forced air currents over the body work well to lower the core
body temperature in HS and are easy to implement in most
This may employ the four physical phenomena for heat centers. We support rapid cooling of HS patients to a core
transfer, namely radiation, conduction, convection, and body temperature of 101.2°F (38.4°C) in the 1st h with an ideal
evaporation. Several cooling methods have been described, cooling rate between 0.1°C and 0.2°C/min.
ranging widely in cost, complexity, and mechanism, though
most seem to be equally effective. Management of organ dysfunction
HS is associated with an inexorable progression to organ
Noninvasive methods are simpler to implement and more dysfunction; hence, managing the complications of HS is an
widely used, including conductive whole‑body immersion, important component of treating the patient.
limb immersion, and ice packs in the neck, axillae, and groin
as well as evaporative wet sheets, water sprays, and fans.[21-23] A study in France[7] found that more than 40% of patients
with HS had severe limitation of activity by Knaus et al.
A prospective nonrandomized study showed that immersion classification 1‑year following HS. Nearly the same proportion
in ice water between 1°C and 3°C of the torso and upper of patients had a strong limitation of activity, while none
legs reduced the core body temperature at twice the had no limitation of activity at 1‑year following the HS. It
rate of exposure to 24.4°C ambient air without any fans is to be noted, however, that the subjects of this study had
(0.2°C/min vs. 0.11°C/min) and reduced rectal temperature several functional limitations to begin with, and only 1 of
by 1°C within 5.6 ± 0.6 s. However, like other studies on the the subjects had no functional limitation prior to having the
subject, it suffers many limitations that reduce the significance HS. Studies in younger subjects[32] found that prominent
of these findings.[24] neurological or behavioral sequelae in HS victims were rare
Invasive methods described include the use of cold water 6 months following hospitalization. Nakamura et al. observed
bladder, gastric, peritoneal, and rectal lavage,[25] as well that 1.5% of 1441 cases of HS exhibited CNS sequelae.
as hemodialysis and cardiopulmonary bypass. Novel Patients presenting with lower GCS scores and higher body
intravascular cooling methods have been described, such as the temperatures at admission were more likely to experience
use of intravascular balloon devices, and initial intravascular these sequelae.
cooling has been shown to have good results.[26] Intravascular While case reports indicate the usefulness of continuous
methods are particularly beneficial in effecting rapid cooling, electroencephalogram monitoring in predicting CNS sequelae,
with rates of up to 0.1°C/min. When compared to conventional there is no prospective, comparable study on adequate
cooling methods, intravascular methods achieved a significant neuromonitoring and the effect of temperature control on the
reduction in the Sequential Organ Failure Assessment score CNS.[33]
in the first 24 h.
Attempts to address the disordered coagulation in HS appear
Unlike external cooling methods, these do not result in promising, with measures including the use of antithrombin
peripheral vasoconstriction but do necessitate the placement type III and thrombomodulin hastening recovery and lowering
of an intravascular balloon catheter, which requires additional markers of inflammation in HS such as interleukin (IL)‑1B,
training and resources. tumor necrosis factor‑a, and IL‑6 levels.[34-37]
Extracorporeal circulation using hemodiafiltration circuits Multiple Japanese authors have reported the use of blood
has also been employed with some benefit;[27] however, it is purification therapy to clear pro‑inflammatory molecules from
important to consider that no prospective, comparative studies the circulation, namely continuous venovenous hemofiltration,
plasma exchange, and continuous renal replacement 7. Argaud L, Ferry T, Le QH, Marfisi A, Ciorba D, Achache P, et al.
therapy (CRRT) in HS, observing lower 30‑day mortality in Short- and long-term outcomes of heatstroke following the 2003 heat
wave in Lyon, France. Arch Intern Med 2007;167:2177-83.
patients treated with CRRT.[18,38] 8. JAMA. Final report of heatstroke study. Japanese Assoc Acute Med
2014;25:846-62.
Another recent case report described the use of a variant of 9. Kalaiselvan MS, Renuka MK, Arunkumar AS. A retrospective study of
plasma exchange called continuous plasma diafiltration, which clinical profile and outcomes of critically ill patients with heat-related
uses smaller pore sizes and more efficiently removes low‑ and illness. Indian J Anaesth 2015;59:715-20.
Downloaded from http://journals.lww.com/cmii by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW
intermediate‑molecular weight albumin‑bound proteins.[30] 10. Kushimoto S, Yamanouchi S, Endo T, Sato T, Nomura R, Fujita M,
et al. Body temperature abnormalities in non-neurological critically ill
A consistent feature of the research studying these costly patients: A review of the literature. J Intensive Care 2014;2:14.
and often time‑consuming methods is a lack of prospective, 11. Miyake Y. Pathophysiology of heat illness: Thermoregulation,
risk factors, and indicators of aggravation. Japan Med Assoc J
comparable studies, with a predominance of case reports or
nYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8KKGKV0Ymy+78= on 03/27/2024
2013;56:167-73.
retrospective studies with low sample sizes that make it hard 12. Yan YE, Zhao YQ, Wang H, Fan M. Pathophysiological factors
to draw conclusions that can be used in clinical practice. underlying heatstroke. Med Hypotheses 2006;67:609-17.
13. Tsai YC, Lam KK, Peng YJ, Lee YM, Yang CY, Tsai YJ, et al. Heat
Interventions to be avoided shock protein 70 and AMP-activated protein kinase contribute to
Several measures in HS have been attempted in the past but 17-DMAG-dependent protection against heat stroke. J Cell Mol Med
2016;20:1889-97.
must be avoided in practice, ranging from the ineffective, such 14. Hausfater P, Megarbane B, Dautheville S, Patzak A, Andronikof M,
as antipyretics and the use of dantrolene,[39,40] to the inherently Santin A, et al. Prognostic factors in non-exertional heatstroke. Intensive
harmful, including the use of anti‑cholinergic, alpha‑adrenergic, Care Med 2010;36:272-80.
salicylate, and nonsteroidal anti‑inflammatory drug medication. 15. Misset B, de Jonghe B, Bastuji-Garin S, Gattolliat O, Boughrara E,
Annane D, et al. Mortality of patients with heatstroke admitted to
It is essential for the primary care physician to learn to intensive care units during the 2003 heat wave in France: A national
differentiate a heat‑related illness from several of its mimics. multiple-center risk-factor study. Crit Care Med 2006;34:1087-92.
16. Li Y, Wang Y, Ma L. An association study of CASQ1 gene polymorphisms
They must also inculcate simple measures to reduce core body and heat stroke. Genomics Proteomics Bioinformatics 2014;12:127-32.
temperature into their management of HS and watch out for the 17. Varghese GM, John G, Thomas K, Abraham OC, Mathai D. Predictors of
potential organ dysfunction, recognizing and referring cases multi-organ dysfunction in heatstroke. Emerg Med J 2005;22:185-7. 12.
which require higher care to facilities that can provide them. 18. Nakae H, Eguchi Y, Saotome T, Yoshioka T, Yoshimura N, Kishi
Y, et al. Multicenter study of plasma diafiltration in patients with acute
liver failure. Ther Apher Dial 2010;14:444-50.
Conclusion 19. Mørch SS, Andersen JD, Bestle MH. Heat stroke: A medical emergency
appearing in new regions. Case Rep Crit Care 2017;2017:6219236.
Heat‑related illness is a widely prevalent disorder with a wide 20. Hifumi T, Kondo Y, Shimazaki J, Oda Y, Shiraishi S, Wakasugi M,
spectrum of severity an ever‑rising burden. Its pathophysiology et al. Prognostic significance of disseminated intravascular coagulation
is complex and involves a systemic inflammatory response due in patients with heat stroke in a nationwide registry. J Crit Care
2018;44:306-11.
to a mismatch between heat production and dissipation. While 21. Weiner JS, Khogali M. A physiological body-cooling unit for treatment
rapid cooling of patients has been shown to be effective, the of heat stroke. Lancet 1980;1:507-9.
evidence is unsatisfactory regarding the competence of various 22. Al-AskaAK,Abu-AishaH,YaqubB,Al-HarthiSS,SallamA.Simplified
measures, as well as the methods to treat organ dysfunction in cooling bed for heatstroke. Lancet 1987;1:381.
23. Hong JY, Lai YC, Chang CY, Chang SC, Tang GJ. Successful treatment
HS. Conducting high‑quality prospective studies comparing of severe heatstroke with therapeutic hypothermia by a noninvasive
various modalities of treatment is the need of the hour. external cooling system. Ann Emerg Med 2012;59:491-3.
Ultimately, it would seem that prevention is far better than cure. 24. Armstrong LE, Crago AE, Adams R, Roberts WO, Maresh CM.
Whole-body cooling of hyperthermic runners: Comparison of two field
Financial support and sponsorship therapies. Am J Emerg Med 1996;14:355-8.
Nil. 25. WhiteJD,RiccobeneE,NucciR,JohnsonC,ButterfieldAB,KamathR.
Evaporation versus iced gastric lavage treatment of heatstroke:
Conflicts of interest Comparative efficacy in a canine model. Crit Care Med 1987;15:748-50.
26. Hamaya H, Hifumi T, Kawakita K, Okazaki T, Kiridume K,
There are no conflicts of interest. Shinohara N, et al. Successful management of heat stroke associated
with multiple-organ dysfunction by active intravascular cooling. Am J
References Emerg Med 2015;33:124.e5-7.
27. Murai A, Nakamura Y, Ichiki R, Yuge R, Umemura T, Ishikura H. Core
1. Lugo-Amador NM, Rothenhaus T, Moyer P. Heat-related illness. Emerg temperature cooling of severe heat stroke patients using extracorporeal
Med Clin North Am 2004;22:315-27, viii. circulation with circuits of hemodialtration. J Japanese Assoc Acute
2. Bouchama A. Heatstroke: A new look at an ancient disease. Intensive Med 2013;24:977-83.
Care Med 1995;21:623-5. 28. Bouchama A, Dehbi M, Chaves-Carballo E. Cooling and hemodynamic
3. Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002;346:1978-88. management in heatstroke: Practical recommendations. Crit Care
4. Tsuruta R, Aruga T, Inoue K, Okudera H, Kitahara T, Shimazaki S. 2007;11:R54.
Predictors of poor outcome in mechanically ventilated patients due to 29. Heled Y, Rav-Acha M, Shani Y, Epstein Y, Moran DS. The “golden
heat-related illness. J Japanese Assoc Acute Med 2010;21:786-91. hour” for heatstroke treatment. Mil Med 2004;169:184-6.
5. Hifumi T, Kondo Y, Shimizu K, Miyake Y. Heat stroke. J Intensive Care 30. Nakae H, Igarashi T, Tajimi K, Noguchi A, Takahashi I, Tsuchida S,
2018;6:30. et al. A case report of pediatric fulminant hepatitis treated with plasma
6. Gaudio FG, Grissom CK. Cooling Methods in Heat Stroke. J Emerg diafiltration. Ther Apher Dial 2008;12:329-32.
Med 2016;50:607-16. 31. Vicario SJ, Okabajue R, Haltom T. Rapid cooling in classic heatstroke:
Effect on mortality rates. Am J Emerg Med 1986;4:394-8. soluble thrombomodulin, ART-123, in patients with sepsis and
32. Royburt M, Epstein Y, Solomon Z, Shemer J. Long-term psychological suspected disseminated intravascular coagulation. Crit Care Med
and physiological effects of heat stroke. Physiol Behav 1993;54:265-7. 2013;41:2069-79.
33. Hachiya S, Okajima M, Nakamura M, Sato K, Koshida Y, Noda T, et al. 37. Sakurai S, Kitada M, Hashimoto S, Harada M, Kimura F, Takahashi T.
Usefulness of continuous electroencephalography in severe heat stroke Two cases of heatstroke-induced disseminated intravascular coagulation
complicated with multi-organ failure: A case report. J Japanese Assoc treated successfully with thrombomodulin alfa. J Japanese Assoc Acute
Acute Med 2016;27:125-9. Med 2013;24:367-73.
34. Pechlaner Ch, Kaneider NC, Djanani A, Sandhofer A, Schratzberger P, 38. Nakae H, Eguchi Y, Yoshioka T, Yoshimura N, Isono M. Plasma
Downloaded from http://journals.lww.com/cmii by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW
Patsch JR. Antithrombin and near-fatal exertional heat stroke. Acta Med diafiltration therapy in patients with postoperative liver failure. Ther
Austriaca 2002;29:107-11. Apher Dial 2011;15:406-10.
35. Hagiwara S, Iwasaka H, Shingu C, Matsumoto S, Uchida T, Noguchi T. 39. Channa AB, Seraj MA, Saddique AA, Kadiwal GH, Shaikh MH,
High-dose antithrombin III prevents heat stroke by attenuating systemic Samarkandi AH. Is dantrolene effective in heat stroke patients? Crit
inflammation in rats. Inflamm Res 2010;59:511-8. Care Med 1990;18:290-2.
nYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8KKGKV0Ymy+78= on 03/27/2024
36. Vincent JL, Ramesh MK, Ernest D, LaRosa SP, Pachl J, Aikawa N, 40. Bouchama A, Cafege A, Devol EB, Labdi O, el-Assil K, Seraj M.
et al. A randomized, double-blind, placebo-controlled, Phase 2b Ineffectiveness of dantrolene sodium in the treatment of heatstroke. Crit
study to evaluate the safety and efficacy of recombinant human Care Med 1991;19:176-80.